Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome
- PMID: 33840729
- DOI: 10.14309/ajg.0000000000001247
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome
Abstract
Introduction: Psychological comorbidities are associated with irritable bowel syndrome (IBS), but little is known about their cumulative effect on its prognosis. We examined this issue in a longitudinal 12-month follow-up study.
Methods: We collected complete demographic, symptom, and psychological comorbidity data (anxiety, depression, somatic symptom disorder, perceived stress, and gastrointestinal symptom-specific anxiety) at baseline from 807 adults who met Rome IV criteria for IBS. At 12 months, we collected data regarding IBS symptom severity and impact, consultation behavior, and treatments commenced from 452 individuals successfully followed up. We examined the cumulative effects of psychological comorbidities at baseline on subsequent IBS disease behavior.
Results: At baseline, among the 807 participants, 177 (21.9%) had 1, 139 (17.2%) 2, 103 (12.8%) 3, 89 (11.0%) 4, and 54 (6.7%) 5 psychological comorbidities. IBS symptom severity at baseline increased significantly with the number of psychological comorbidities (72.2% of those with 5 psychological comorbidities reported severe symptoms, vs 29.1% of those with none, P < 0.001). Among 452 (56.0%) participants followed up at 12 months, those with a higher number of psychological comorbidities at baseline were significantly more likely to have seen a gastroenterologist (33.3% of those with 5 psychological comorbidities, vs 21.4% of those with none, P = 0.001), cycle through more treatments (P < 0.0001), to report more severe IBS symptoms (66.7% with 5, vs 24.4% with none, P < 0.001) and continuous abdominal pain (22.1% with none, vs 61.9% with 5, P < 0.001), and to report that symptoms impacted on daily activities ≥50% of the time (90.5% with 5, vs 41.2% with none, P < 0.001).
Discussion: The prognosis of individuals with Rome IV-defined IBS worsens according to incremental increases in psychological comorbidity. This has important clinical and research implications.
Copyright © 2021 by The American College of Gastroenterology.
Similar articles
-
The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity.Am J Gastroenterol. 2014 Feb;109(2):224-33. doi: 10.1038/ajg.2013.410. Epub 2014 Jan 14. Am J Gastroenterol. 2014. PMID: 24419481 Free PMC article.
-
Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.Clin Gastroenterol Hepatol. 2022 Mar;20(3):569-577.e3. doi: 10.1016/j.cgh.2021.04.043. Epub 2021 May 3. Clin Gastroenterol Hepatol. 2022. PMID: 33957271
-
Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?Aust N Z J Psychiatry. 2005 Sep;39(9):807-15. doi: 10.1080/j.1440-1614.2005.01686.x. Aust N Z J Psychiatry. 2005. PMID: 16168039 Clinical Trial.
-
The interface of psychiatry and irritable bowel syndrome.Curr Psychiatry Rep. 2004 Jun;6(3):210-5. doi: 10.1007/s11920-004-0066-0. Curr Psychiatry Rep. 2004. PMID: 15142474 Review.
-
Irritable bowel syndrome: relations with functional, mental, and somatoform disorders.World J Gastroenterol. 2014 May 28;20(20):6024-30. doi: 10.3748/wjg.v20.i20.6024. World J Gastroenterol. 2014. PMID: 24876725 Free PMC article. Review.
Cited by
-
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13. United European Gastroenterol J. 2022. PMID: 35695704 Free PMC article. Review.
-
Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.Nat Rev Gastroenterol Hepatol. 2025 Apr;22(4):228-251. doi: 10.1038/s41575-024-01033-9. Epub 2025 Jan 27. Nat Rev Gastroenterol Hepatol. 2025. PMID: 39870943 Review.
-
The gut microbiome in disorders of gut-brain interaction.Gut Microbes. 2024 Jan-Dec;16(1):2360233. doi: 10.1080/19490976.2024.2360233. Epub 2024 Jul 1. Gut Microbes. 2024. PMID: 38949979 Free PMC article. Review.
-
Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.Neurogastroenterol Motil. 2022 Nov;34(11):e14391. doi: 10.1111/nmo.14391. Epub 2022 May 9. Neurogastroenterol Motil. 2022. PMID: 35531932 Free PMC article.
-
Serotoninergic Mechanisms of Action in the Relaxant Properties of Saccharomyces boulardii CNCM I-745 on the Intestine.Dig Dis Sci. 2025 Jan;70(1):191-202. doi: 10.1007/s10620-024-08786-y. Epub 2024 Dec 11. Dig Dis Sci. 2025. PMID: 39661276 Free PMC article.
References
-
- Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016;150:1393–407.
-
- Ford AC, Sperber AD, Corsetti M, et al. Irritable bowel syndrome. Lancet 2020;396:1675–88.
-
- Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5:908–17.
-
- Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 2021;160(1):99–114.e3.
-
- Flacco ME, Manzoli L, De Giorgio R, et al. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: A meta-analysis. Eur Rev Med Pharmacol Sci 2019;23:2986–3000.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous